spacer
The Healthcare Sales & Marketing Network celebrates 21 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  United Therapeutics 

 HSMN NewsFeed - 20 Jun 2019
CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business
Regenerative Medicine Wound Care
 HSMN NewsFeed - 29 Apr 2019
United Therapeutics Announces FDA Approval Of XPS(TM) And Steen Solution(TM) Used To Perform Centralized Ex-Vivo Lung Perfusion Services
Devices FDA
 HSMN NewsFeed - 8 Apr 2019
United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 11 Mar 2019
Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks
Regenerative Medicine Wound Care
 HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Nov 2018
CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
Devices Regenerative Medicine Licensing
 HSMN NewsFeed - 17 Sep 2018
Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Sep 2018
United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Aug 2018
United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 8 Jun 2018
Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 30 Apr 2018
United Therapeutics To Acquire SteadyMed Ltd.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Jan 2018
Corsair Pharma and United Therapeutics Enter into Strategic Collaboration to Advance Novel Treprostinil Prodrugs
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
Biopharmaceuticals FDA Licensing
 HSMN NewsFeed - 23 Oct 2017
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 12 Apr 2017
Respira Therapeutics Announces Collaboration with United Therapeutics to Treat Pulmonary Hypertension
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 24 Feb 2016
Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs
Biopharmaceuticals Oncology Venture Capital Licensing
 HSMN NewsFeed - 17 Aug 2015
European Commission Grants Marketing Authorisation for Unituxin(TM) (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Dec 2014
United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2013
United Therapeutics Receives Subpoena From Office of Inspector General
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2013
Former US Secretary of Health and Human Services and Wisconsin Governor Joins Tenex Health Board of Directors
Devices Personnel
 HSMN NewsFeed - 5 Sep 2012
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
Regenerative Medicine Oncology
 HSMN NewsFeed - 6 Aug 2012
Life of Cancer Patient Suffering From Bone Marrow Failure Saved Following Treatment With Pluristem's PLX Cells
Regenerative Medicine Oncology
 HSMN NewsFeed - 26 Aug 2011
Medistem Submits Response to FDA Clinical Hold
Regenerative Medicine FDA
 HSMN NewsFeed - 24 Aug 2011
FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2010
United Therapeutics Corporation Withdraws European Marketing Authorization Application for Tyvaso for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 May 2009
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2009
United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostinil (Tyvaso)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Nov 2008
Lilly Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Nov 2008
FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2008
New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Nov 2007
Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2007
ViRexx Announces Second OvaRex(R) MAb Phase III Trial Reaches 118th Relapse Event
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 May 2007
Medicomp Inc. Announces Industry First Ambulatory Atrial Fibrillation Burden Monitoring Service for Cardiac Patients
Devices Cardiology Monitoring
 HSMN NewsFeed - 7 May 2007
ViRexx Announces Appointment of Directors and Interim Chief Executive Officer and Formation of Special Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2007
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
Biopharmaceuticals Devices Cardiology
 HSMN NewsFeed - 27 Mar 2007
United Therapeutics and Mochida Pharmaceutical Sign Remodulin Distribution Agreement for Japan
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Feb 2007
United Therapeutics Announces Pulmonary Hypertension Opinion Leaders' Guidance On Intravenous Therapies
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2007
Results of Inhaled Treprostinil Controlled Pilot Studies Reported in the Journal of the American College Of Cardiology
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Dec 2006
United Therapeutics Affiliate Initiates First-Ever Gene-Therapy Trial for Pulmonary Arterial Hypertension
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 13 Oct 2006
Neurotechnology Industry Organization Launched to Advance Treatments for Brain and Nervous System Illnesses
Devices Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Jun 2006
Supernus Pharmaceuticals Announces Partnership with United Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Jun 2006
Lung Rx Announces FDA Agreement to Expand TRIUMPH Study and Appointment of Eugene Sullivan, M.D. as Chief Medical Officer
Biopharmaceuticals FDA Personnel
 HSMN NewsFeed - 21 Mar 2006
United Therapeutics Announces FDA Approval of Expanded Label Indication and Satisfaction of Subpart H Accelerated Approval Commitment
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jan 2006
Israeli Ministry of Health Approves Intravenous Dosing of Remodulin(R) to Treat Pulmonary Arterial Hypertension
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 24

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 24 additional stories matching:
United Therapeutics
(Password required)
FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.